相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands
Christopher Southan et al.
NUCLEIC ACIDS RESEARCH (2016)
Gastrin stimulates MMP-1 expression in gastric epithelial cells: putative role in gastric epithelial cell migration
J. Dinesh Kumar et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2015)
Effect of netazepide, a gastrin/CCK2 receptor antagonist, on gastric acid secretion and rabeprazole-induced hypergastrinaemia in healthy subjects
Malcolm Boyce et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2015)
THE CONCISE GUIDE TO PHARMACOLOGY 2015/16: G protein-coupled receptors
Stephen P. H. Alexander et al.
BRITISH JOURNAL OF PHARMACOLOGY (2015)
MicroRNAs in tumorigenesis, metastasis, diagnosis and prognosis of gastric cancer
C. Jiang et al.
CANCER GENE THERAPY (2015)
Intermittent treatment of recurrent type-1 gastric carcinoids with somatostatin analogues in patients with chronic autoimmune atrophic gastritis
Sara Massironi et al.
DIGESTIVE AND LIVER DISEASE (2015)
Exome sequencing identifies ATP4A gene as responsible of an atypical familial type I gastric neuroendocrine tumour
Oriol Calvete et al.
HUMAN MOLECULAR GENETICS (2015)
Gastric neuroendocrine tumors: prevalence in Europe, USA, and Japan, and rationale for treatment with a gastrin/CCK2 receptor antagonist
Malcolm Boyce et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2015)
Phenotype, origin and estimated prevalence of a common long QT syndrome mutation: a clinical, genealogical and molecular genetics study including Swedish R518X/KCNQ1 families
Annika Winbo et al.
BMC CARDIOVASCULAR DISORDERS (2014)
Lanreotide in Metastatic Enteropancreatic Neuroendocrine Tumors
Martyn E. Caplin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Classification, clinicopathologic features and treatment of gastric neuroendocrine tumors
Ting-Ting Li et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Systematic review: gastric cancer incidence in pernicious anaemia
L. Vannella et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2013)
Netazepide, a gastrin/CCK2 receptor antagonist, causes dose-dependent, persistent inhibition of the responses to pentagastrin in healthy subjects
Malcolm Boyce et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2013)
Iron-deficiency anaemia, gastric hyperplasia, and elevated gastrin levels due to potassium channel dysfunction in the Jervell and Lange-Nielsen Syndrome
Annika Winbo et al.
CARDIOLOGY IN THE YOUNG (2013)
Long-term follow-up of a large series of patients with type 1 gastric carcinoid tumors: data from a multicenter study
Dimitrios Thomas et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2013)
Autoimmune atrophic gastritis-pathogenesis, pathology and management
William L. Neumann et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2013)
Netazepide, a Gastrin Receptor Antagonist, Normalises Tumour Biomarkers and Causes Regression of Type 1 Gastric Neuroendocrine Tumours in a Nonrandomised Trial of Patients with Chronic Atrophic Gastritis
Andrew R. Moore et al.
PLOS ONE (2013)
Metastatic type 1 gastric carcinoid: A real threat or just a myth?
Simona Grozinsky-Glasberg et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2013)
Single oral doses of netazepide (YF476), a gastrin receptor antagonist, cause dose-dependent, sustained increases in gastric pH compared with placebo and ranitidine in healthy subjects
M. Boyce et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2012)
Treatment of gastric carcinoids type 1 with the gastrin receptor antagonist netazepide (YF476) results in regression of tumours and normalisation of serum chromogranin A
R. Fossmark et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2012)
Prevalence, mutation spectrum, and cardiac phenotype of the Jervell and Lange-Nielsen syndrome in Sweden
Annika Winbo et al.
EUROPACE (2012)
Type I Gastric Carcinoids: A Prospective Study on Endoscopic Management and Recurrence Rate
Elettra Merola et al.
NEUROENDOCRINOLOGY (2012)
ENETS Consensus Guidelines for the Management of Patients with Gastroduodenal Neoplasms
Gianfranco Delle Fave et al.
NEUROENDOCRINOLOGY (2012)
Gastrin stimulates expression of plasminogen activator inhibitor-1 in gastric epithelial cells
Kristin G. Norsett et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2011)
p27: A Barometer of Signaling Deregulation and Potential Predictor of Response to Targeted Therapies
Seth A. Wander et al.
CLINICAL CANCER RESEARCH (2011)
Classification and pathology of gastroenteropancreatic neuroendocrine neoplasms
Guenter Kloeppel
ENDOCRINE-RELATED CANCER (2011)
Elevated serum gastrin levels in Jervell and Lange-Nielsen syndrome: A marker of severe KCNQ1 dysfunction?
Kathryn S. Rice et al.
HEART RHYTHM (2011)
Laparoscopic Antrectomy for the Treatment of Type I Gastric Carcinoid Tumors
Junko Ozao-Choy et al.
JOURNAL OF SURGICAL RESEARCH (2010)
NANETS Treatment Guidelines Well-Differentiated Neuroendocrine Tumors of the Stomach and Pancreas
Matthew H. Kulke et al.
PANCREAS (2010)
The CCK2 receptor antagonist, YF476, inhibits Mastomys ECL cell hyperplasia and gastric carcinoid tumor development
M. Kidd et al.
REGULATORY PEPTIDES (2010)
Gastric endocrine tumors type I: treatment with long-acting somatostatin analogs
D. Campana et al.
ENDOCRINE-RELATED CANCER (2008)
Long-acting somatostatin analogues are an effective treatment for type 1 gastric carcinoid tumours
Simona Grozinsky-Glasberg et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2008)
Increased gastric expression of MMP-7 in hypergastrinemia and significance for epithelial-mesenchymal signaling
Andrea Varro et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2007)
Gastrin - active participant or bystander in gastric carcinogenesis?
Susan A. Watson et al.
NATURE REVIEWS CANCER (2006)
Review article: pathogenesis and management of gastric carcinoid tumours
M. D. Burkitt et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2006)
Gastrin-induced apoptosis contributes to carcinogenesis in the stomach
Guanglin Cui et al.
LABORATORY INVESTIGATION (2006)
Gastric carcinoids - A temporal increase with proton pump introduction
N Hodgson et al.
SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES (2005)
Plasma chromogranin A in patients with autoimmune chronic atrophic gastritis, enterochromaffin-like cell lesions and gastric carcinoids
M Peracchi et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2005)
Gastrin: old hormone, new functions
G Dockray et al.
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY (2005)
Treatment of ECL cell carcinoids with octreotide LAR
V Fykse et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2004)
A 50-year analysis of 562 gastric carcinoids: Small tumor or larger problem?
IM Modlin et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2004)
Cholecystokinin antagonists: Pharmacological and therapeutic potential
R Herranz
MEDICINAL RESEARCH REVIEWS (2003)
Spontaneous ECL cell carcinomas in cotton rats: natural course and prevention by a gastrin receptor antagonist
TC Martinsen et al.
CARCINOGENESIS (2003)
Serum chromogranin A as a screening test for gastric enterochromaffin-like cell hyperplasia during acid-suppressive therapy
S Sanduleanu et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2001)
The gastrins: Their production and biological activities
GJ Dockray et al.
ANNUAL REVIEW OF PHYSIOLOGY (2001)
Effect of cholecystokinin-2 receptor blockade on rat stomach ECL cells - A histochemical, electron-microscopic and chemical study
D Chen et al.
CELL AND TISSUE RESEARCH (2000)
分享论文
